NVO Novo Nordisk
$37.82 -2.70%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-2.70%
YTD
-25.70%
P/E
10.09
P/B
7.44
ROE
59.1%
Div yield
1.0%
Beta
0.92
Market cap
$1.18T
RSI (14)
38
Next earnings
Feb 3, 2027
Same sector · Health Care
Compare NVO with JNJ and AMGN →Follow NVO in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$38.44
Close
$37.82
Day high
$39.12
Day low
$37.75
Volume
13.0M
Latest headlines
Novo Gets FDA Approval For First-Of-Its-Kind Weekly Growth Hormone Treatment For Children With Turner Syndrome
Yahoo Finance · Nov 20
Novo's Sogroya® receives FDA approval as the first and only once-weekly, long-acting growth hormone for children with Turner Syndrome (TS)
Yahoo Finance · Nov 20
Forget the Headlines: Novo Nordisk's (NVO) 4.6% Dividend Yield Is the Real Story for Patient Investors
The dividend is hefty · Nov 20
nference and Novo partner to advance understanding of cardiometabolic disease and healthy ageing
Yahoo Finance · Nov 18
Novo Nordisk (NVO) Stock May Be Undervalued On Raised 2026 Outlook
Yahoo Finance · Nov 18
Novo Nordisk (NVO) Could Be 47% Below Fair Value Following Its AI Push
Yahoo Finance · Nov 18
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
6-K Nov 16, 2026 View → 6-K Nov 9, 2026 View → 6-K Nov 5, 2026 View → 6-K Nov 4, 2026 View → 6-K Nov 3, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell NVO. Try it in the Lab to size a position and see the risk.